PWA
EVLV icon

Physician Wealth Advisors’s Evolv Technologies EVLV Stock Holding History

Physician Wealth Advisors’s Portfolio EVLV Stock Details EVLV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$430 Buy
+74
New +$464 ﹤0.01% 2202

Other funds holding EVLV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SPCM
Stoic Point Capital Management Palo Alto, California $121M AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
DCI
Data Collective IV Palo Alto, California $78.6M AUM 55.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Physician Wealth Advisors's EVLV Position: Q2 2026 in Review

Physician Wealth Advisors opened a new position in Evolv Technologies (EVLV) in Q2 2026: 74 shares worth $430. The stake represents ﹤0.01% of the portfolio and ranks #2202 among its holdings.

260 funds tracked by Wall St. Rank hold EVLV as of Q2 2026.

  • Physician Wealth Advisors held 74 shares of Evolv Technologies worth $430 as of Q2 2026.
  • Evolv Technologies was a new Physician Wealth Advisors position in Q2 2026.
  • Evolv Technologies made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #2202 holding.
  • 260 funds tracked by Wall St. Rank held Evolv Technologies as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.